Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

65992 1510824253HCLSReviewUkraineNovember2017.pdf
Energy Boardroom

US Capitol Capsule: Patent rejections expected to rise under post-Myriad guidelines

10.03.2014 / Pharma Times

What that means for biopharmaceutical firms, said Palo Alto, California lawyer Antoinette Konski, a partner with Foley & Lardner, is likely an increase in rejections by the US PTO of patent claims under the boundaries of Section 101 of the US Patent Act,…

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: